You are here

  • Home
  • Archive
  • Volume 6, Issue 1
  • Re-induction using whole cell melanoma vaccine genetically modified to melanoma stem cells-like beyond recurrence extends long term survival of high risk resected patients - updated results

Article metrics

Article menu

Download PDFPDF

Clinical Trials Monitor
Re-induction using whole cell melanoma vaccine genetically modified to melanoma stem cells-like beyond recurrence extends long term survival of high risk resected patients - updated results

 

Online download statistics by month:

Online download statistics by month: December 2019 to March 2024

AbstractFullPdf
Dec 2019220
Jan 2020770
Feb 202012121
Mar 202016162
Apr 2020991
May 202026261
Jun 202012121
Jul 202021211
Aug 202011115
Sep 202025251
Oct 202020202
Nov 202012121
Dec 2020776
Jan 2021992
Feb 202111115
Mar 202115157
Apr 2021552
May 202111114
Jun 202113134
Jul 202112124
Aug 2021663
Sep 2021212112
Oct 20219918
Nov 2021111113
Dec 202117178
Jan 202214151
Feb 202216179
Mar 202210102
Apr 202214155
May 2022171712
Jun 2022272815
Jul 202223237
Aug 202224243
Sep 2022313111
Oct 202226288
Nov 2022996
Dec 202214142
Jan 2023121214
Feb 2023292913
Mar 202310101
Apr 202313148
May 2023886
Jun 202316174
Jul 202315159
Aug 202310113
Sep 2023991
Oct 20239108
Nov 202311115
Dec 202313165
Jan 2024663
Feb 202474746
Mar 202418184
Total798811275